52
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Low incidence of endometrial hyperplasia with acceptable bleeding patterns in women taking sequential hormone replacement therapy with dydrogesterone

&
Pages 275-281 | Published online: 05 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Nicholas Panay, Maria Pritsch & Jeannette Alt. (2007) Cyclical dydrogesterone in secondary amenorrhea: Results of a double-blind, placebo-controlled, randomized study. Gynecological Endocrinology 23:11, pages 611-618.
Read now
A. Ferenczy, M. M. Gelfand, P. H. M. van de Weijer & J. E. Rioux. (2002) Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17β-estradiol combined with sequential 5-20 mg dydrogesterone. Climacteric 5:1, pages 26-35.
Read now

Articles from other publishers (9)

Ciro Comparetto & Franco Borruto. (2023) Treatments and Management of Menopausal Symptoms: Current Status and Future Challenges. OBM Geriatrics 07:03, pages 1-47.
Crossref
Petra Stute, Linus Josef Walker, Astrid Eicher, Elena Pavicic, Argyrios Kolokythas, Susanne Theis, Marc von Gernler, Michael von Wolff & Sabrina Vollrath. (2023) Progestogens for endometrial protection in combined menopausal hormone therapy: A systematic review. Best Practice & Research Clinical Endocrinology & Metabolism, pages 101815.
Crossref
Alfred O. Mueck & Thomas Römer. (2019) Choice of progestogen for endometrial protection in combination with transdermal estradiol in menopausal women. Hormone Molecular Biology and Clinical Investigation 37:2.
Crossref
Bo Liang, Ling Wu, Hui Xu, Chun Wai Cheung, Wen Ying Fung, Sze Wai Wong & Chi Chiu Wang. (2018) Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice. Reproductive Biology and Endocrinology 16:1.
Crossref
Adolf E. Schindler. (2009) Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium. Maturitas 65, pages S3-S11.
Crossref
Meira Epplein, Susan D. Reed, Lynda F. Voigt, Katherine M. Newton, Victoria L. Holt & Noel S. Weiss. (2009) Endometrial Hyperplasia Risk in Relation to Recent Use of Oral Contraceptives and Hormone Therapy. Annals of Epidemiology 19:1, pages 1-7.
Crossref
C. Quereux, B. Pornel, C. Bergeron & A. Ferenczy. (2006) Continuous combined hormone replacement therapy with 1mg 17?-oestradiol and 5mg dydrogesterone (Femoston?-conti): Endometrial safety and bleeding profile. Maturitas 53:3, pages 299-305.
Crossref
Bruno Pornel, Olivier Chevallier & J. Coen Netelenbos. (2002) Oral 17??-estradiol (1 mg) continuously combined with dydrogesterone improves the serum lipid profile of postmenopausal women. Menopause 9:3, pages 171-178.
Crossref
Eduardo L. Franco & Alex Ferenczy. 2002. Cancer Precursors. Cancer Precursors 287 303 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.